CRBP$4.093.08%-0.13
Corbus Pharmaceuticals Holdings Inc (CRBP)
Date: 2026-11-02 16:00O: 4.17H: 4.23L: 4.07C: 4.09Vol: 6.543k
Corbus Pharmaceuticals Holdings Inc stock is traded at $4.09, with a volume of 32,440. It is down -3.08% in the last 24 hours and down -33.28% over the past month. Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
Previous Close:
$4.22
Open:
$4.17
24h Volume:
32,440
Relative Volume:
0.03
Market Cap:
$79.11M
Revenue:
$1.54M
Net Income/Loss:
-$84.53M
P/E Ratio:
-
EPS:
-$5.81
Net Cash Flow:
-$73.65M
1W Performance:
+2.51%
1M Performance:
-33.28%
6M Performance:
-60.29%
1Y Performance:
-66.34%
1-Day Range:
$4.06$4.23
1-Week Range:
$3.95$4.34
52-Week Range:
$3.87$17.24
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile
Name
Corbus Pharmaceuticals Holdings IncSector
HealthcareIndustry
BiotechnologyPhone
617-963-0103Address
500 RIVER RIDGE DRIVE, NORWOOD, MA, USACompare CRBP vs VRTX, REGN, MRNA, ARGX, ONC
| Stocks | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|
CRBP Corbus Pharmaceuticals Holdings Inc | $79.11M | $1.54M | -$84.53M | -$73.65M | -$5.81 |
 VRTX Vertex Pharmaceuticals Inc | $143.16B | $12.34B | $4.34B | $3.71B | $16.87 |
 REGN Regeneron Pharmaceuticals Inc | $98.99B | $14.92B | $4.42B | $3.79B | $41.04 |
 MRNA Moderna Inc | $88.97B | $2.23B | -$3.19B | -$1.60B | -$8.15 |
 ARGX Argen X Se Adr | $55.77B | $4.16B | $1.29B | $734.26M | $19.58 |
 ONC Beone Medicines Ltd Adr | $41.73B | $5.76B | $514.49M | $1.10B | $4.48 |
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Financials Data
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Insider Trading
- Saxena Nishant CAug 11 '26Chief Business Officer
- Transaction
- Buy
- Cost
- $9.63
- #Shares
- 2,600
- Value ($)
- 25,036
- #Shares Total
- 77,900
- Stifel, Nicolaus & Company, InAug 07 '26Officer
- Transaction
- Proposed Sale
- Cost
- $10.08
- #Shares
- 17,000
- Value ($)
- 171,396
- #Shares Total
- 0
- Cohen YuvalAug 07 '26Chief Executive Officer
- Transaction
- Sale
- Cost
- $10.08
- #Shares
- 17,000
- Value ($)
- 171,396
- #Shares Total
- 157,316
- Moran Sean F.Aug 07 '26Chief Financial Officer
- Transaction
- Sale
- Cost
- $10.08
- #Shares
- 12,000
- Value ($)
- 120,971
- #Shares Total
- 84,694
- Stifel, Nicolaus & Company, InAug 07 '26Officer
- Transaction
- Proposed Sale
- Cost
- $10.08
- #Shares
- 12,000
- Value ($)
- 120,971
- #Shares Total
- 0
- Smethurst DominicJul 27 '26Officer
- Transaction
- Proposed Sale
- Cost
- $9.20
- #Shares
- 23,025
- Value ($)
- 211,818
- #Shares Total
- 0
- Kung WinstonJun 10 '26Director
- Transaction
- Sale
- Cost
- $7.91
- #Shares
- 2,026
- Value ($)
- 16,033
- #Shares Total
- 12,140
- Altmeyer AnneJun 10 '26Director
- Transaction
- Sale
- Cost
- $7.91
- #Shares
- 2,412
- Value ($)
- 19,088
- #Shares Total
- 7,579
- Jenkins John KennethJun 10 '26Director
- Transaction
- Sale
- Cost
- $7.91
- #Shares
- 4,800
- Value ($)
- 37,986
- #Shares Total
- 3,833
- Saxena Nishant CJun 03 '26Chief Business Officer
- Transaction
- Buy
- Cost
- $7.58
- #Shares
- 9,000
- Value ($)
- 68,220
- #Shares Total
- 75,300
